(PharmaNewsWire.Com, December 18, 2017 ) According to the North America Surface Plasmon Resonance Market Research Report, the market was worth USD 238.72 million in 2016 and estimated to be growing at a CAGR of 5.10 %, to reach USD 306.12 million by 2021. View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-surface-plasmon-resonance-market-4856/North...
(PharmaNewsWire.Com, December 18, 2017 ) According to the report North America Prefilled Syringes Market, published by Market Data Forecast, the market is projected to reach USD 1.8 billion by 2021, at a CAGR of 5.6% from 2016 to 2021.A common way for infectious diseases to spread is through the...
(PharmaNewsWire.Com, December 18, 2017 ) The North America Diagnostic Catheter Market was worth USD 1.05 billion in 2016 and estimated to be growing at a CAGR of 7.2%, to reach USD 1.49 billion by 2021. Catheters are medical devices which are inserted inside a patient’s body. It is made up of materials...
(PharmaNewsWire.Com, December 18, 2017 ) According to the report North America Molecular Cytogenetics Market, published by Market Data Forecast, the market is projected to reach USD 870 million by 2021, at a CAGR of 10.5% from 2016 to 2021.Molecular biology and cytogenetics are the two major areas...
(PharmaNewsWire.Com, December 18, 2017 ) According to the report Asia Pacific Orthodontic Supplies Market, published by Market Data Forecast, the market is projected to reach USD 1.2 billion by 2021, at a CAGR of 8.6% from 2016 to 2021.Orthodontia is that subject of dentistry which involves doctors...
(PharmaNewsWire.Com, December 18, 2017 ) The North America mycoplasma testing market was worth USD 148.8 Million in 2016 and is estimated to be growing at a CAGR of 11.5%, to reach USD 256.5 Million by 2021. Mycoplasmas are small bacteria which do not possess a cell wall and they are one of the...
(PharmaNewsWire.Com, December 18, 2017 ) According to the report Head and Neck Cancer Diagnostics, published by Market Data Forecast, the Europe market is projected to reach USD 3.35 billion by 2021, at a CAGR of 10.85% from 2016 to 2021.While Head and Neck cancer is rated as being among the top...
(PharmaNewsWire.Com, December 18, 2017 ) North America Anatomy Pathology Market was worth USD 6.16 billion in 2016 and is estimated to be growing at a CAGR of 5.51%, to reach USD 8.05 billion by 2021. The market is having the highest share among all the regions. Anatomy Pathology is the branch of...
(PharmaNewsWire.Com, December 18, 2017 ) The North America Antinuclear Antibody Test Market was worth USD 312.93 million in 2016 and expected to reach USD 553.96 million by 2021 at a CAGR of 12.10%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody...
(PharmaNewsWire.Com, December 18, 2017 ) The North America Proteins Assays Market was worth USD 486.4 million in 2016 and estimated to be growing at a CAGR of 10.65%, to reach USD 806.77 million by 2021. Rising application of protein content determination in various fields related to pharmacy and...
(PharmaNewsWire.Com, December 18, 2017 ) According to the report, North America Patient positioning systems Market was worth USD 346.5 million in 2016 and estimated to be growing at a CAGR of 4.3%, to reach USD 427.68 million by 2021. Patient positioning systems are the medical devices which are...
(PharmaNewsWire.Com, December 18, 2017 ) Asia-Pacific Medical Device 3D Printing market is estimated at USD 107.38 million in 2015 and is poised to reach USD 370.69 million by 2020, growing at a CAGR of 28.12%. 3D printing is being considered as the next greatest chapter in the industrial uprising....
(PharmaNewsWire.Com, December 18, 2017 ) The North America Healthcare Information Exchange Market was worth $325.05 million in 2016 and estimated to be growing at a CAGR of 8.45%, to reach $487.64 million by 2021.The North America Healthcare Information Exchange market has matured and a number of...
(PharmaNewsWire.Com, December 18, 2017 ) The North America Needles Market was worth USD 1.6 billion in 2016 and estimated to be growing at a CAGR of 7.9%, to reach USD 2.34 billion by 2021. The market is showcasing high growth potential in the mentioned period. It will continue to expand with the...
(PharmaNewsWire.Com, December 18, 2017 ) Asia-Pacific Acute Ischemic Stroke Treatment and Diagnosis Market was worth $326.52 million in 2016 and estimated to be growing at a CAGR of 7.9%, to reach $477.55 million by 2021. Acute Ischemic stroke can be defined as loss of function in certain parts...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
